Lynette K Rogers1, Mary Robbins2, Duaa Dakhlallah3, Zhaogang Yang4, L James Lee4, Madison Mikhail5, Gerard Nuovo5, Gloria S Pryhuber6, Gerald McGwin7, Clay B Marsh3, Trent E Tipple8. 1. 1 Center for Perinatal Research, The Research Institute at Nationwide Children's Hospital, Columbus, Ohio. 2. 2 Division of Neonatology and. 3. 3 Division of Pulmonary, Allergy, Critical Care, Sleep Medicine, College of Medicine; and. 4. 4 The Center for Affordable Nanoengineering of Polymeric Biomedical Devices, The Ohio State University, Columbus, Ohio. 5. 5 Phylogeny, Inc., Powell, Ohio. 6. 6 Department of Pediatrics, University of Rochester Medical Center, Rochester, New York; and. 7. 7 Department of Epidemiology and. 8. 8 Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama.
Abstract
RATIONALE: Bronchopulmonary dysplasia remains a significant cause of neonatal morbidity; however, the identification of novel targets to predict or prevent the development of bronchopulmonary dysplasia remains elusive. Proper microRNA (miR)-17∼92 cluster is necessary for normal lung development, and alterations in expression are reported in other pulmonary diseases. The overall hypothesis for our work is that altered miR-17∼92 cluster expression contributes to the molecular pathogenesis of bronchopulmonary dysplasia. OBJECTIVES: The current studies tested the hypothesis that alterations in miR-17∼92 cluster and DNA methyltransferase expression are present in bronchopulmonary dysplasia. METHODS: miR-17∼92 cluster expression, promoter methylation, and DNA methyltransferase expression were determined in autopsy lung samples obtained from premature infants who died with bronchopulmonary dysplasia, or from term/near-term infants who died from nonrespiratory causes. Expression of miR-17∼92 cluster members miR-17 and -19b was measured in plasma samples collected in the first week of life from a separate cohort of preterm infants at a second institution in whom bronchopulmonary dysplasia was diagnosed subsequently. MEASUREMENTS AND MAIN RESULTS: Autopsy tissue data indicated that miR-17∼92 expression is significantly lower in bronchopulmonary dysplasia lungs and is inversely correlated with promoter methylation and DNA methyltransferase expression when compared with that of control subjects without bronchopulmonary dysplasia. Plasma sample analyses indicated that miR-17 and -19b expression was decreased in infants who subsequently developed bronchopulmonary dysplasia. CONCLUSIONS: Our data are the first to demonstrate altered expression of the miR-17∼92 cluster in bronchopulmonary dysplasia. The consistency between our autopsy and plasma findings further support our working hypothesis that the miR-17∼92 cluster contributes to the molecular pathogenesis of bronchopulmonary dysplasia.
RATIONALE: Bronchopulmonary dysplasia remains a significant cause of neonatal morbidity; however, the identification of novel targets to predict or prevent the development of bronchopulmonary dysplasia remains elusive. Proper microRNA (miR)-17∼92 cluster is necessary for normal lung development, and alterations in expression are reported in other pulmonary diseases. The overall hypothesis for our work is that altered miR-17∼92 cluster expression contributes to the molecular pathogenesis of bronchopulmonary dysplasia. OBJECTIVES: The current studies tested the hypothesis that alterations in miR-17∼92 cluster and DNA methyltransferase expression are present in bronchopulmonary dysplasia. METHODS:miR-17∼92 cluster expression, promoter methylation, and DNA methyltransferase expression were determined in autopsy lung samples obtained from premature infants who died with bronchopulmonary dysplasia, or from term/near-term infants who died from nonrespiratory causes. Expression of miR-17∼92 cluster members miR-17 and -19b was measured in plasma samples collected in the first week of life from a separate cohort of preterm infants at a second institution in whom bronchopulmonary dysplasia was diagnosed subsequently. MEASUREMENTS AND MAIN RESULTS: Autopsy tissue data indicated that miR-17∼92 expression is significantly lower in bronchopulmonary dysplasia lungs and is inversely correlated with promoter methylation and DNA methyltransferase expression when compared with that of control subjects without bronchopulmonary dysplasia. Plasma sample analyses indicated that miR-17 and -19b expression was decreased in infants who subsequently developed bronchopulmonary dysplasia. CONCLUSIONS: Our data are the first to demonstrate altered expression of the miR-17∼92 cluster in bronchopulmonary dysplasia. The consistency between our autopsy and plasma findings further support our working hypothesis that the miR-17∼92 cluster contributes to the molecular pathogenesis of bronchopulmonary dysplasia.
Authors: William M Maniscalco; Richard H Watkins; Michael A O'Reilly; Colleen P Shea Journal: Am J Physiol Lung Cell Mol Physiol Date: 2002-11 Impact factor: 5.464
Authors: Gerard J Nuovo; Michela Garofalo; Nicola Valeri; Vicki Roulstone; Stefano Volinia; David E Cohn; Mitch Phelps; Kevin J Harrington; Richard Vile; Alan Melcher; Evanthia Galanis; Sarah Sehl; Rob Adair; Karen Scott; Ailsa Rose; Giles Toogood; Matthew C Coffey Journal: Mod Pathol Date: 2012-06-15 Impact factor: 7.842
Authors: David M Poitz; Antje Augstein; Christine Gradehand; Georg Ende; Alexander Schmeisser; Ruth H Strasser Journal: Mol Immunol Date: 2013-08-01 Impact factor: 4.407
Authors: Sébastien Bonnet; Olivier Boucherat; Roxane Paulin; Danchen Wu; Charles C T Hindmarch; Stephen L Archer; Rui Song; Joseph B Moore; Steeve Provencher; Lubo Zhang; Shizuka Uchida Journal: Am J Physiol Cell Physiol Date: 2019-09-04 Impact factor: 4.249
Authors: Shaheen Durrani-Kolarik; Caylie A Pool; Ashley Gray; Kathryn M Heyob; Mary J Cismowski; Gloria Pryhuber; L James Lee; Zhaogang Yang; Trent E Tipple; Lynette K Rogers Journal: Am J Physiol Lung Cell Mol Physiol Date: 2017-05-04 Impact factor: 5.464
Authors: Mary E Robbins; Duaa Dakhlallah; Clay B Marsh; Lynette K Rogers; Trent E Tipple Journal: Am J Physiol Lung Cell Mol Physiol Date: 2016-09-30 Impact factor: 5.464
Authors: María Álvarez-Fuente; Laura Moreno; Jane A Mitchell; Irwin K Reiss; Paloma Lopez; Dolores Elorza; Liesbeth Duijts; Alejandro Avila-Alvarez; Luis Arruza; Manuel Ramirez Orellana; Eugenio Baraldi; Patrizia Zaramella; Santiago Rueda; Álvaro Gimeno-Díaz de Atauri; Hercília Guimarães; Gustavo Rocha; Elisa Proença; Bernard Thébaud; Maria Jesús Del Cerro Journal: Pediatr Res Date: 2018-11-21 Impact factor: 3.756